| Model Number |
N/A |
| Medical Device Problem Code |
Low Test Results (2458)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
03/11/2026
|
|
Type of Reportable Event
|
Malfunction
|
|
Event or Problem Description
|
|
The customer reported that the erroneously depressed creatinine (cre2) results were obtained on four patient samples on the dimension exl with lm integrated chemistry system.The initial results were reported to the physician(s) and were not questioned.The same samples were repeated on the original system and obtained higher results.The repeat results obtained were considered correct and reported to the physician(s).There are no known reports of patient intervention or adverse health consequences due to the erroneously depressed creatinine (cre2) results.
|
| |
|
Additional Manufacturer Narrative
|
|
A united states (us) customer contacted the siemens healthcare diagnostics remote services center (rsc) regarding erroneously depressed creatinine (cre2) results obtained on four patient samples on the dimension exl with lm integrated chemistry system.Siemens healthineers has confirmed a potential for imprecision with dimension creatinine (cre2) quality control (qc) and patient sample results when using lot numbers ga6307 and ba7005 on the dimension exl 200 integrated chemistry system.Us customers were notified through an urgent medical device correction (umdc, letter dc26-01.A.Us) and urgent field safety notice (ufsn, letter dc26-01.A.Ous) titled "imprecision with quality control and patient results for dimension creatinine lot numbers ga6307 and ba7005".The communication was directed to all customers who received dimension creatinine lot numbers ga6307 and ba7005 informing them of the issue and providing instructions the customer must follow.
|
| |
|
Search Alerts/Recalls
|